Spectrum Wealth Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$19.2K Hold
150
﹤0.01% 205
2024
Q4
$19.8K Hold
150
﹤0.01% 203
2024
Q3
$21.8K Sell
150
-23
-13% -$3.33K ﹤0.01% 207
2024
Q2
$23.7K Hold
173
﹤0.01% 247
2024
Q1
$23.7K Hold
173
﹤0.01% 249
2023
Q4
$23.5K Buy
+173
New +$21.1K ﹤0.01% 224

Other funds holding IBB

Spectrum Wealth Counsel's IBB Position: Q1 2025 in Review

Spectrum Wealth Counsel held its iShares Biotechnology ETF (IBB) position steady in Q1 2025 at 150 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Spectrum Wealth Counsel first reported a position in IBB in Q4 2023 and has held it in 6 quarters since. The position peaked at $23.7K in Q2 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Spectrum Wealth Counsel held 150 shares of iShares Biotechnology ETF worth $19.2K as of Q1 2025.
  • Spectrum Wealth Counsel left its iShares Biotechnology ETF share count unchanged in Q1 2025.
  • iShares Biotechnology ETF made up ﹤0.01% of Spectrum Wealth Counsel's portfolio in Q1 2025, its #205 holding.
  • Spectrum Wealth Counsel first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 6 quarters since.
  • Spectrum Wealth Counsel's iShares Biotechnology ETF position peaked at $23.7K in Q2 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.